SkinBioTherapeutics plc (AIM:SBTX)
London flag London · Delayed Price · Currency is GBP · Price in GBX
24.30
+0.20 (0.83%)
Mar 28, 2025, 12:35 PM GMT+1

SkinBioTherapeutics Cash Flow Statement

Millions GBP. Fiscal year is Jul - Jun.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2016
Period Ending
Dec '24 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 2019 - 2016
Net Income
-2.58-2.88-2.84-2.79-1.43-1.5
Upgrade
Depreciation & Amortization
0.290.180.050.040.010.01
Upgrade
Stock-Based Compensation
--00.050.060.16
Upgrade
Other Operating Activities
0.190.150.08-0.08-0.070.09
Upgrade
Change in Accounts Receivable
0.30.17-0.050.13-0.20.17
Upgrade
Change in Inventory
0.10.10.09-0.12--
Upgrade
Change in Accounts Payable
-0.47-0.440.020.10.070.18
Upgrade
Operating Cash Flow
-2.16-2.73-2.65-2.67-1.56-0.89
Upgrade
Capital Expenditures
--0.01-0.09---
Upgrade
Sale (Purchase) of Intangibles
-0.19-0.17-0.08-0.1-0.11-0.07
Upgrade
Other Investing Activities
-3.53-2.110--0-
Upgrade
Investing Cash Flow
-3.72-2.3-0.17-0.1-0.11-0.07
Upgrade
Short-Term Debt Issued
-1.47----
Upgrade
Total Debt Issued
2.421.47----
Upgrade
Long-Term Debt Repaid
--0.04-0.04-0.04-0-
Upgrade
Net Debt Issued (Repaid)
2.381.43-0.04-0.04-0-
Upgrade
Issuance of Common Stock
1.943.122.62-4.12-
Upgrade
Other Financing Activities
-0.04-0.04-0.26---
Upgrade
Financing Cash Flow
4.284.512.32-0.044.12-
Upgrade
Net Cash Flow
-1.6-0.51-0.49-2.82.45-0.97
Upgrade
Free Cash Flow
-2.16-2.74-2.73-2.67-1.56-0.89
Upgrade
Free Cash Flow Margin
-80.71%-226.80%-2071.02%-3575.44%--
Upgrade
Free Cash Flow Per Share
-0.01-0.01-0.02-0.02-0.01-0.01
Upgrade
Cash Interest Paid
0.040.04----
Upgrade
Cash Income Tax Paid
--0.18-0.26-0.12--0.21
Upgrade
Levered Free Cash Flow
-1.49-1.79-1.86-1.85-1.17-0.48
Upgrade
Unlevered Free Cash Flow
-1.46-1.76-1.85-1.84-1.17-0.48
Upgrade
Change in Net Working Capital
-0.04-0.07-0.14-0.030.19-0.45
Upgrade
Updated Dec 10, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.